Skip to main content
Premium Trial:

Request an Annual Quote

Stephen Tang, James Weyhenmeyer, Al Latimer, Stephen Christian, Mary Spellman, Paul Risser, Thomas Filarski, Jean-Pierre Garnier, Gary LeBeau, Jeffrey Matus, William White, Gordon Nixon, Howard Alper, Felix Chee, Ron Venter, Alejandro Calderon-Urrea, Cour

University City Science Center Taps Olympus America Executive as President/CEO
Stephen Tang has been named president and CEO of the University City Science Center in Philadelphia effective Feb. 4, following a nationwide search.
Tang is group vice president and general manager with Olympus America, overseeing US operations for the company’s global life science businesses. Before joining Olympus in 2005, he was president and CEO of Millennium Cell, an Eatontown, NJ-based energy technology firm that he led through its initial public offering in 2000.
Earlier, Tang served as vice president and managing director of the global pharmaceutical and healthcare practice of AT Kearney; as vice president and co-managing director of the global chemical and environmental practice for Gemini Consulting, now Cap Gemini; and as assistant director and senior research engineer at the Lehigh University Center for Molecular Bioscience and Biotechnology in Bethlehem, Pa.
Tang earned a doctorate in chemical engineering from Lehigh University and an MBA for executives from the Wharton School of Business at the University of Pennsylvania. He is also a graduate of the College of William and Mary in Virginia with a BS in Chemistry.

University of Illinois Administrator Named a Senior VP with SUNY Research Foundation
James Weyhenmeyer has been appointed senior vice president of the Research Foundation of the State University of New York and senior vice provost for research at SUNY, a newly created position, effective March 3. His duties include leading the R&D and technology programs of the Research Foundation, which helps SUNY acquire and manage external funds to advance research and technology transfer activity; and promoting research opportunities among SUNY campuses.
Weyhenmeyer most recently served as the interim vice president for technology and economic development at the University of Illinois. He previously held several positions at UI, including associate vice president for academic affairs and associate vice president for economic development and corporate relations.

Weyhenmeyer earlier was executive director of IllinoisVENTURES, which promotes the early-stage development of technology-based companies deriving from regional research institutions and universities. He serves as a member of the board of governors of Argonne National Laboratory and the board of directors of Fermi National Accelerator Laboratory. Last month, Weyhenmeyer was elected to the Royal Swedish Academy of Engineering Sciences.

Weyhenmeyer is a professor of cell biology, pathology and neuroscience at the University of Illinois, with faculty appointments on the Urbana/Champaign campus. 
He received his BA from Knox College, his PhD from Indiana University, and his postdoctoral training at the University of Iowa.

Enterprise Florida Names Florida Chamber VP to External Affairs Post
Al Latimer has been appointed senior vice president of the external affairs and investor relations division of Enterprise Florida, the state’s public-private economic development agency. He succeeds Chris Hart IV, who left to become president/CEO role at Workforce Florida.
Latimer previously was a vice president of the division responsible for economic development government, legislative and partner/stakeholder relations. The division oversees Enterprise Florida’s investor recruitment and retention efforts, involvement with partner economic development organizations, government relations, military and defense programs and corporate communications.
Before joining Enterprise Florida, Latimer spent four years as vice president of government relations for the Florida Chamber of Commerce in Tallahassee. From 1989 to 1994 he served as executive director of the Jacksonville Sports Development Authority, and for three years before that was regional director for the Governor’s Council on Fitness & Sports in Gainesville, Fla. 
From 1979 to 1985, he played professional football for the NFL’s Philadelphia Eagles, San Francisco 49ers, and Detroit Lions.
A native of Winter Park, Fla., Latimer earned a bachelor’s degree in business administration at Walsh College in Troy, Mich.

Berkeley County, Md., Hires New Leader for its Development Authority
Stephen Christian has been named the new leader for the Berkeley County (Md.) Development Authority, following a vote last week by the authority board. While he will succeed Robert (Bob) Crawford, who retired from the position effective Dec. 31, the effective date of Christian’s appointment had not been set at deadline.
Christian will be paid $83,000 annually — $13,000 more than Crawford’s salary, according to the Herald-Mail of Hagerstown, Md., citing unnamed “officials familiar with the hiring.” Christian was one of 16 applicants for the job, which was first advertised in August.
Christian most recently sold commercial and residential real estate; served as a business development specialist for the Hagerstown-Washington County Economic Development Commission; held an economic development position with Montgomery County that included expanding its biotech and telecommunications sectors; and worked for the West Virginia Economic Development Office.

Revance CMO Joins Manhattan Pharmaceuticals to Oversee Clinical Operations
Mary Spellman has been appointed consultant head of dermatology and drug development for Manhattan Pharmaceuticals, overseeing all clinical operations related to the development of its product pipeline.
Spellman joins the company as an independent contractor and will continue to have other clients at this time. She succeeds Alan Harris, who left the company to “pursue other business opportunities in the endocrinology field,” according to a company press release.
Spellman previously served as chief medical officer and senior vice president of development for Revance Therapeutics, where she was responsible for clinical and nonclinical R&D. Earlier she was senior director of medical research for the immunology unit of Biogen Idec, where she led all phases of global immunology clinical trials for drugs designed to treat psoriasis, asthma, allergic rhinitis, and Crohn's disease. She has held clinical dermatology positions at Connetics and Novartis, and was a practicing medical dermatologist for over seven years.
She earned her medical degree from the Medical College of Wisconsin and a BSci degree from Loyola University of Chicago.

Ex-College President, Museum Director Named to Head Oklahoma’s EDGE Fund Board
Paul Risser has been appointed executive director of Oklahoma’s Economic Development Generating Excellence, also known as EDGE, Fund Policy Board. The EDGE fund was created in 2003 by Gov. Brad Henry, with the goal of growing into a $1 billion endowment to fund research projects in biotech and other technology specialties.
Risser, a former state chancellor of higher education, spent the past year as acting director of the Smithsonian’s National Museum of Natural History in Washington, DC.
Risser served as president of Oregon State University from 1996 to 2002, and of Miami University of Ohio from 1993 to 1996. From 1986 to 1993, Risser served as vice president for research and then as provost for academic affairs at the University of New Mexico. Previously, he served as the chief of the Illinois Natural History Survey at the University of Illinois from 1981 to 1986.
Risser received his bachelor’s degree in biology from Grinnell College in Iowa in 1961. He received his master’s degree in the major in 1965, and his doctorate two years later from the University of Wisconsin.

Patent Lawyer on Pharma, Medical Device Cases Named to Law Firm’s Board of Directors
Thomas Filarski, chair of the chemical group at Brinks Hofer Gilson & Lione, has been named to the intellectual property law firm’s board of directors. Filarski conducts litigation and offers counsel in generic pharmaceutical, medical device and chemical and other patent matters in federal court and the International Trade Commission.
Filarski is the author of the chapter "Patent Defenses" in BNA Books' 2005 Patent Litigation Series Handbook, now in its second edition. He has spoken on patent and litigation topics at the International Intellectual Property Law Symposia at Oxford University and other forums. Filarski is a charter member of the newly formed Richard Linn American Inn of Court chapter in Chicago and he serves on the board of trustees for the Licensing Executives Society, where he holds the office of secretary. 
Filarski holds a BA in chemistry from Loyola University of Chicago, a MSci in chemical engineering from Michigan Technological University, and a JD from DePaul University College of Law.

GlaxoSmithKline CEO Wins Leadership Award from Pennsylvania Bio
Jean-Pierre Garnier, the CEO of GlaxoSmithKline, will be honored with Pennsylvania Bio's 2008 Hubert JP Schoemaker Leadership Award at the association’s annual dinner on March 19 at the Sheraton Philadelphia City Center Hotel.
The life sciences industry group presents the award each year to a biosciences leader “who best exemplifies the spirit of innovation in the Commonwealth of Pennsylvania and has demonstrated a vision for the industry and a vision for improving the lives of patients.”
A founder of Centocor — which sponsors the award — and Neuronyx, Schoemaker was named CEO of GSK in January 2001 following the merger of SmithKline Beecham and Glaxo Wellcome. He joined SmithKline Beecham in 1990 as president of its pharmaceutical business in North America and advanced to chairman of pharmaceuticals from 1994 until his appointment as chief operating officer in 1995. Five years later, he became that company’s CEO.
Prior to SmithKline Beecham, he served in various management positions at Schering-Plough.
Garnier holds a PhD in pharmacology and an MS in pharmaceutical science from the University of Louis Pasteur in France. As a Fulbright Scholar, he earned an MBA from Stanford University in 1974; in 2002, he was honored with the Fulbright Association's lifetime achievement medal.

Connecticut State Senator Honored For Support of Bioscience, High Tech Industries
Connecticut State Sen. Gary LeBeau (D- East Hartford), co-chairman of the legislature's commerce committee, was recently honored by two state business organizations for the state’s commitment to bioscience and high-tech industries.
Connecticut United for Research Excellence awarded LeBeau its Award of Merit, an annual award given each year to individuals and organizations who have made significant contributions to the Connecticut bioscience community.
Two days later on Dec. 6, the Connecticut Technology Council recognized LeBeau as its 2007 "Public Policy Leader of the Year" for his support of its economic development efforts — including an angel investment tax credit bill that he championed last year, but which failed to pass the legislature.

In 2005, LeBeau found success supporting Gov. Jodi Rell's successful effort to boost state spending for stem cell research. That year Rell signed into law a $100 million, 10-year measure which also created a research advisory committee, a peer review committee, and a research fund to award research grants for embryonic or human adult stem cell research.


Three Business Leaders Join Board of Directors of MaRS Discovery District
MaRS Discovery District in Toronto has named three business leaders to its board of directors:
Geoffrey Matus, president of Mandukwe, also serves as chairman of Cidel Bank & Trust, Tricon Capital Group, NexGen Financial Services, and Biltrite Industries. He is a member of the governing council of the University of Toronto; a board member of the Canadian Opera Company; and an honorary director of Baycrest, where he was a past board chair. He is a law graduate of Columbia University in New York, and a graduate of the University of the Witwatersrand in South Africa.

William White has been president of DuPont Canada since 2006, and has spent the past 33 years with the company in marketing and sales positions in its titanium technologies, chemical solutions enterprise, and safety resources units. He is a graduate of Purdue University and currently chairs Purdue’s mechanical engineering advisory committee.

Gordon Nixon, the president and CEO of RBC, chairs the Canadian Council of Chief Executives, and has been recently named Canada’s Outstanding CEO of 2007 by the Financial Post. He is a board member of the Hospital for Sick Children, the International Monetary Conference and Catalyst Canada, as well as an advisory board member of DaimlerChrysler Canada.

Nixon has agreed to succeed MaRS founding chair John Evans as chair of the district’s board in 2009.

Stepping down are Howard Alper, former vice-president of research at the University of Ottawa and recently named chair of the Canadian government’s new Science, Technology and Innovation Council; Felix Chee, former president and CEO of University of Toronto Asset Management; and Ron Venter, recently retired professor of mechanical engineering and assistant vice president of the University of Toronto.


CalState Honors Professor for Training Minority Students in Biomedical Careers
Alejandro Calderon-Urrea, an associate professor of biology at California State University, Fresno, received the 2008 Andreoli Biotechnology Service Award on Jan. 12 at the 20th annual CSU Biotechnology Symposium in Oakland, Calif. The award recognizes a faculty member from the 23-campus CalState system who has made outstanding contributions to the development of biotechnology.

Since joining the Fresno State faculty in 1997, Calderon-Urrea has served as the principal investigator for a grant that helps train minority students for biomedical study and employment. He received the 2006 provost's award for graduate teaching and mentoring and the 2005 Claude Laval Jr. award for innovative technology and research.

He obtained his bachelor's degree from Universidad del Valle in Colombia, his master's degree from Vrije Universiteit Brussel in Belgium and his PhD from Yale University. His postdoctoral work focused on understanding the molecular mechanisms involved during plant-pathogen interaction.


Marketing Firm Hires Veteran Copywriter as Project Coordinator
Courtney Willey has been hired as a project coordinator by Kelly MarCom, a Sanford, NC-based marketing firm whose clients include biotechnology companies as well as businesses specializing in commercial and economic development, banking and finance, real estate development, and healthcare.
Willey previously worked for ARES Systems Group and Inspire Creative Studios, where she assisted on writing copy for marketing proposals, Web sites, brochures and print advertisements; as well as carrying out research for the development of TV programs.
Willey resides in Cary and holds a bachelor’s degree in mass communication from Campbell University in Buies Creek, NC.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.